McCormack P M, Bains M S, Burt M E, Martini N, Chaglassian T, Hidalgo D A
Department of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, New York.
Arch Surg. 1989 Feb;124(2):158-61. doi: 10.1001/archsurg.1989.01410020028003.
Chest wall recurrence following radiation and hormonal therapy is an uncommon but serious and disabling condition. A chest wall ulcer secondary to treatment for recurrence also presents the same dilemma. Over the past 35 years, the Thoracic Service at our institution has treated 35 patients for these problems by surgical resection and reconstruction. Eight patients were seen after the first recurrence, six after the second, ten after the third, and ten after the fourth. One patient had chest wall resection with mastectomy when recurrence followed radiation therapy. Following resection of the tumor, 21 patients had reconstruction using mesh or a mesh "sandwich." There were no operative deaths and no respirator need. Twenty patients are alive from five to 120 months, with a median of 50 months. One of 35 patients had chest wall recurrence. Surgical resection of recurrent mammary carcinoma resistant to all other therapy is a viable alternative for both palliation and cure.
放疗和激素治疗后胸壁复发是一种罕见但严重且致残的疾病。因复发治疗继发的胸壁溃疡也面临同样的困境。在过去35年里,我们机构的胸外科通过手术切除和重建治疗了35例此类问题患者。首次复发后就诊8例,第二次复发后6例,第三次复发后10例,第四次复发后10例。1例患者在放疗后复发时行胸壁切除加乳房切除术。肿瘤切除后,21例患者使用网片或网片“三明治”进行重建。无手术死亡病例,也无需使用呼吸机。20例患者存活5至120个月,中位生存期为50个月。35例患者中有1例出现胸壁复发。对所有其他治疗均耐药的复发性乳腺癌进行手术切除,对于缓解症状和治愈都是一种可行的选择。